Influence of body mass index on cardiovascular risk in rheumatoid arthritis varies across anti-citrullinated protein antibody status and biologic use

By sjmartinez • April 6, 2025

Karpouzas GA, Gonzalez-Gay MA, Corrales A, Myasoedova E, Rantapää-Dahlqvist S, Sfikakis PP, Dessein P, Hitchon C, Pascual-Ramos V, Contreras-Yáñez I, Colunga-Pedraza IJ, Galarza-Delgado DA, Azpiri-Lopez JR, Semb AG, van Riel PLCM, Misra DP, Patrick D, Bridal Logstrup B, Hauge EM, Kitas G, Ormseth SR; for An inTernationAl Cardiovascular Consortium for Rheumatoid Arthritis (ATACC-RA). Influence of body mass index on cardiovascular risk in rheumatoid arthritis varies across anti-citrullinated protein antibody status and biologic use. RMD Open. 2025 Apr 5;11(2):e005464. doi: 10.1136/rmdopen-2025-005464. PMID: 40187772.

Tags: Anti-Citrullinated Protein Antibodies, Arthritis, biological therapy, cardiovascular diseases, Harbor UCLA, Publications, Rheumatoid, Rheumatology

A Review of Randomized Controlled Trials for Vitiligo Therapies Published Between 2013 and 2023

Maverakis Ramirez N, Jaeger ZJ, Lee DJ. A Review of Randomized Controlled Trials for Vitiligo Therapies Published Between 2013 and 2023. Cureus. 2026 Jul 8;18(7):e112280.[...]

Proteomic Mediators of Chronic Obstructive Pulmonary Disease Phenotypes and Coronary Artery Calcification Burden in Ever Smokers

Abbasi A, Ahmad K, Pratte KA, Moore J, DeMeo DL, Manubolu VS, Kinninger A, Tiller NB, Bowler RP, Budoff M, Casaburi R, Rossiter HB. Proteomic[...]

Mannan immunoassay for diagnosis of invasive mucormycosis: assay development, preclinical testing and evaluation in an animal model

Burnham-Marusich AR, Pandit V, Alkhazraji S, Gu Y, Zayac KR, Wingard JR, Culver EL, Walish JJ, Ibrahim AS, Kozel TR. Mannan immunoassay for diagnosis of[...]